Ibrahim Yakoub-Agha

Professeur des Universités - Praticien Hospitalier

Centre Hospitalier Régional Universitaire de Lille

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Prof. Ibrahim Yakoub-Agha is a Université Professor and Hospital Practitioner at the Centre Hospitalier Régional Universitaire de Lille, France. His research focuses on hematopoietic cell transplantation, including outcomes related to ABO compatibility and HLA mismatching, as well as therapeutic approaches for hematologic malignancies. He has contributed to recent studies examining the efficacy of CAR T-cell therapy and the management of infections post-transplantation.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Grzegorz Władysław Basak

University Clinical Centre

POLAND

View details

Per Ljungman

Karolinska University Hospital

SWEDEN

View details

Didier Blaise

Professor of Medicine

Aix-Marseille University

FRANCE

View details

Jakob R Passweg

Head

University Hospital Basel

SWITZERLAND

View details

Donal P. McLornan

UNITED KINGDOM

View details

Eleni Gavriilaki

Aristotle University of Thessaloniki

GREECE

View details

Gerard Socie

FRANCE

View details

Cristina CASTILLA LLORENTE

Institut Gustave Roussy

FRANCE

View details

Achilles Anagnostopoulos

Chief Scientific Director

GREECE

View details

Hildegard Greinix

Division Head

Medical University of Graz

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ibrahim Yakoub-Agha

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation

Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation

Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMT.

The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT.

Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study

Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS

Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies

A second round of anti-CD19 CAR T-cell therapy in diffuse large B-cell lymphoma: when persistence pays off

Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee

Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years—a registry-based study by the Acute Leukemia Working Party of the EBMT

Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT

Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy

Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS

Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study

Haemophagocytic lymphohistiocytosis following allogeneic hematopoietic cell transplantation from mismatched unrelated donors associated with low CD34 and CD3 cell counts in the graft

Sexual and Emotional Health after Allogeneic Hematopoietic Cell Transplantation: A Comprehensive Review and Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Collaborators (10)

Grzegorz Władysław Basak

Per Ljungman

Didier Blaise

Jakob R Passweg

Donal P. McLornan

Eleni Gavriilaki

Gerard Socie

Cristina CASTILLA LLORENTE

Achilles Anagnostopoulos

Hildegard Greinix

Make your next move.